A detailed history of Panagora Asset Management Inc transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 67,723 shares of ITOS stock, worth $541,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,723
Previous 131,553 48.52%
Holding current value
$541,784
Previous $1.95 Million 64.6%
% of portfolio
0.0%
Previous 0.01%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$10.09 - $17.97 $644,044 - $1.15 Million
-63,830 Reduced 48.52%
67,723 $691,000
Q2 2024

Jul 29, 2024

BUY
$10.33 - $18.09 $111,429 - $195,136
10,787 Added 8.93%
131,553 $1.95 Million
Q1 2024

May 07, 2024

SELL
$9.89 - $13.64 $37,038 - $51,081
-3,745 Reduced 3.01%
120,766 $1.65 Million
Q4 2023

Feb 08, 2024

SELL
$8.57 - $11.06 $186,526 - $240,720
-21,765 Reduced 14.88%
124,511 $1.36 Million
Q3 2023

Oct 31, 2023

BUY
$10.95 - $14.6 $276,345 - $368,460
25,237 Added 20.85%
146,276 $1.6 Million
Q2 2023

Aug 11, 2023

BUY
$12.93 - $18.05 $55,663 - $77,705
4,305 Added 3.69%
121,039 $1.6 Million
Q1 2023

May 11, 2023

BUY
$13.02 - $22.62 $863,265 - $1.5 Million
66,303 Added 131.47%
116,734 $1.59 Million
Q4 2022

Feb 13, 2023

BUY
$17.77 - $21.6 $250,130 - $304,041
14,076 Added 38.72%
50,431 $984,000
Q3 2022

Nov 14, 2022

BUY
$18.6 - $27.25 $278,349 - $407,796
14,965 Added 69.96%
36,355 $693,000
Q2 2022

Aug 15, 2022

BUY
$16.57 - $35.1 $354,432 - $750,789
21,390 New
21,390 $441,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $285M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.